BIO Honors Renee Ellmers as BIO Legislator of the Year.
Press Release Summary:
April 23, 2014 - BIO announced its selection of Congresswoman Renee Ellmers (R-NC) as Legislator of the Year for 2013–2014. Calling Ellmers "a champion of America's biotechnology industry," BIO President and CEO Jim Greenwood cited her leadership and support of such critical issues as Medicare Part B, Medicare Part D, and release of sequestered of FDA user fees. Greenwood continued by praising Ellmers' work on EnergyÂ and Commerce Committee's Health Subcommittee.
Original Press Release
Congresswoman Ellmers Honored as BIO Legislator of the Year
Press release date: April 9, 2014
“Her important work on the Energy & Commerce Committee’s Health Subcommittee enables biotech companies to bring life-saving and life-enhancing technologies to market, while ensuring America remains the world leader in life science innovation.”
“As a champion of America's biotechnology industry, Congresswoman Ellmers has distinguished herself for leadership and support of a number of critically important issues, including Medicare Part B, Medicare Part D, and the release of sequestered of FDA user fees," said BIO President and CEO Jim Greenwood. "Her important work on the Energy & Commerce Committee’s Health Subcommittee enables biotech companies to bring life-saving and life-enhancing technologies to market, while ensuring America remains the world leader in life science innovation.”
"The life science industry in North Carolina provides more than $59 billion in annual economic impact and provides jobs, both directly and indirectly, for over 228,000 people. Congresswoman Ellmers has been an invaluable resource for the biotechnology community – both in the 2nd District and North Carolina at large,” said Sam Taylor, President of the North Carolina Biosciences Organization. "We thank Congresswoman Ellmers for her outstanding leadership and dedication to supporting the innovative capacity and job creating potential of American life science companies, and we congratulate her on receiving this award."
More than 250 biotechnology industry representatives from over 40 states, representing hundreds of thousands of American workers, will participate in hundreds of meetings with Members of the House and Senate during the BIO Legislative Day Fly-In. Participants will discuss issues critical to the biotechnology industry including, adequate reimbursement for vital therapies under Medicare, FDA funding, tax policy, and capital formation issues relevant to biotechnology companies.
Photos of the award presentation are available upon request.
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.
Upcoming BIO Events
BIO IP Counsels Committee Conference
April 23-25, 2014
Palm Springs, CA
World Congress on Industrial Biotechnology
May 12-15, 2014
BIO International Convention
June 23-26, 2014
San Diego, CA
Livestock Biotech Summit
September 16-18, 2014
Sioux Falls, SD
Biotechnology Industry Organization (BIO)
George Goodno, 202-962-9660